Video yükleniyor...

Video Yüklenemedi

Ana Sayfaya Dön

HER2+ metastatic BTC Pt 3/3! Here we 🗣️ AEs, management, step down dosing for availabms Rx options (TDxD & Zanidatamab) w/ Rachna Shroff, MD, MS, FASCO Full 📢: 🌟 🌟 🌟Also on the “Oncology Brothers” podcast! #OncTwitter #MedTwitter #gism

OncBrothers's profile picture

Oncology Brothers

21,516 subscribers

12,063 görüntüleme • 1 yıl önce •via X (Twitter)

Sağlık & İyilikBilim & TeknolojiEğitim#OncTwitter#MedTwitter#gism
LIVE

Anya Rossi• Live Now

Private livecam show

0 Yorum

Yorum bulunmuyor

Orijinal gönderinin yorumları burada görünecek

Benzer Videolar

Part 2/3 on SCLC! Here we discuss AEs and management of our available options in Extensive Stage small cell w/ Misty Dawn Shields Full 📢 🌟 🌟 🌟Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter #lcsm #CME
0:54

Part 2/3 on SCLC! Here we discuss AEs and management of our available options in Extensive Stage small cell w/ Misty Dawn Shields Full 📢 🌟 🌟 🌟Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter #lcsm #CME

Oncology Brothers

17,402 görüntüleme • 10 ay önce

GI Malignancies Highlights from #ESMO25 with Rachna Shroff, MD, MS, FASCO! ✅ #DYNAMICIII & #PEGASUS ✅ #STELLAR303 ✅ #MATTERHORN ✅ #FORTITUDE101 Full Discussion: - - Also on “Oncology Brothers” podcast #OncTwitter #gism ESMO - Eur. Oncology OncUpdates
1:09

GI Malignancies Highlights from #ESMO25 with Rachna Shroff, MD, MS, FASCO! ✅ #DYNAMICIII & #PEGASUS ✅ #STELLAR303 ✅ #MATTERHORN ✅ #FORTITUDE101 Full Discussion: - - Also on “Oncology Brothers” podcast #OncTwitter #gism ESMO - Eur. Oncology OncUpdates

Oncology Brothers

19,203 görüntüleme • 8 ay önce

#GISeries: #Zolbetuximab was approved based off #GLOW & #SPOTLIGHT! We discussed the design, findings, sequencing and AEs/management w/ Kohei shitara Full Discussion: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism
2:05

#GISeries: #Zolbetuximab was approved based off #GLOW & #SPOTLIGHT! We discussed the design, findings, sequencing and AEs/management w/ Kohei shitara Full Discussion: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism

Oncology Brothers

28,134 görüntüleme • 1 yıl önce

#GISeries: #Tislelizumab is approved based off #RATIONALE305 & #RATIONALE306! We🗣️the design, findings, PDL1 testing + AEs w/ Anwaar Saeed Full 🗣️: ⭐️ ⭐️ ⭐️ Also on “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism
1:59

#GISeries: #Tislelizumab is approved based off #RATIONALE305 & #RATIONALE306! We🗣️the design, findings, PDL1 testing + AEs w/ Anwaar Saeed Full 🗣️: ⭐️ ⭐️ ⭐️ Also on “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism

Oncology Brothers

10,933 görüntüleme • 1 yıl önce

Treatment Algorithm series, MPN: PV & ET w/ Andrew Kuykendall MD ✅ Work-up ✅ Rx Options ✅ AEs & Management Full discussion: - - Also on the “Oncology Brothers” podcast #HemeTwitter #OncTwitter OncUpdates
1:04

Treatment Algorithm series, MPN: PV & ET w/ Andrew Kuykendall MD ✅ Work-up ✅ Rx Options ✅ AEs & Management Full discussion: - - Also on the “Oncology Brothers” podcast #HemeTwitter #OncTwitter OncUpdates

Oncology Brothers

39,910 görüntüleme • 11 ay önce

#ToxCheck: Discussion on common chemotherapies in #PancreaticCancer & how to manage their side effects w/ Rachna Shroff, MD, MS, FASCO & Midhun Malla Full 📢 ⭐️ ⭐️ “Oncology Brothers” podcast #OncTwitter #5FU #NaLIri #Irinotecan #GemNabPac #Oxaliplatin OncoAlert
1:18

#ToxCheck: Discussion on common chemotherapies in #PancreaticCancer & how to manage their side effects w/ Rachna Shroff, MD, MS, FASCO & Midhun Malla Full 📢 ⭐️ ⭐️ “Oncology Brothers” podcast #OncTwitter #5FU #NaLIri #Irinotecan #GemNabPac #Oxaliplatin OncoAlert

Oncology Brothers

27,057 görüntüleme • 1 yıl önce

GI ASCO highlights from #GI26 with Rachna Shroff, MD, MS, FASCO ✅ MATTERHORN (update) ✅ HERIZON-GEA-01 ✅ BREAKWATER ✅ SWOG Cancer Research Network COMMIT Full Discussion: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter OncUpdates
1:41

GI ASCO highlights from #GI26 with Rachna Shroff, MD, MS, FASCO ✅ MATTERHORN (update) ✅ HERIZON-GEA-01 ✅ BREAKWATER ✅ SWOG Cancer Research Network COMMIT Full Discussion: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter OncUpdates

Oncology Brothers

16,959 görüntüleme • 5 ay önce

#Cabozantinib is now approved in #NET based off #CABINET study! We discussed the design, findings, sequencing, and AEs w/ Aman Chauhan Full 🗣️: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism #GiOnc
1:05

#Cabozantinib is now approved in #NET based off #CABINET study! We discussed the design, findings, sequencing, and AEs w/ Aman Chauhan Full 🗣️: ⭐️ ⭐️ Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter #gism #GiOnc

Oncology Brothers

21,289 görüntüleme • 1 yıl önce

#ToxCheck: AntiVEGF & AntiEGFR have been approved for years. Just before #GI25, w/ Pashtoon Kasi MD, MS we 🗣️ key AEs & management strategies for these drugs! Full 📢 ⭐️ ⭐️ “Oncology Brothers” podcast #OncTwitter #bevacizumab #panitumumab #cetuximab #crcsm
1:13

#ToxCheck: AntiVEGF & AntiEGFR have been approved for years. Just before #GI25, w/ Pashtoon Kasi MD, MS we 🗣️ key AEs & management strategies for these drugs! Full 📢 ⭐️ ⭐️ “Oncology Brothers” podcast #OncTwitter #bevacizumab #panitumumab #cetuximab #crcsm

Oncology Brothers

20,720 görüntüleme • 1 yıl önce

Zongertinib is now approved for Her2+ NSCLC based off Beamion Lung-1! We had a chance to 🗣️ Her2 testing, trial, findings, AEs and sequencing w/ Joshua Sabari, MD Full 🗣️: ⭐️ ⭐️ Also on “Oncology Brothers” podcast #OncTwitter #lcsm OncUpdates
1:11

Zongertinib is now approved for Her2+ NSCLC based off Beamion Lung-1! We had a chance to 🗣️ Her2 testing, trial, findings, AEs and sequencing w/ Joshua Sabari, MD Full 🗣️: ⭐️ ⭐️ Also on “Oncology Brothers” podcast #OncTwitter #lcsm OncUpdates

Oncology Brothers

25,876 görüntüleme • 10 ay önce

#ToxCheck: CART is approved for multiple heme malignancies. Join Surbhi Sidana, MD & Jason Westin, MD FACP FASCO as we discuss key AEs & management strategies: Full 📢 ⭐️ ⭐️ ⭐️ “Oncology Brothers” podcast #MedTwitter #HemeTwitter #mmsm #lymsm
1:02

#ToxCheck: CART is approved for multiple heme malignancies. Join Surbhi Sidana, MD & Jason Westin, MD FACP FASCO as we discuss key AEs & management strategies: Full 📢 ⭐️ ⭐️ ⭐️ “Oncology Brothers” podcast #MedTwitter #HemeTwitter #mmsm #lymsm

Oncology Brothers

18,973 görüntüleme • 1 yıl önce

ToxCheck: AEs for ADCs approved in Lung Cancer & how to manage them with Jacob sands: ✅ TDXd: HER2+ ✅ DatoDXd: EGFR+ ✅ TelisoV: C-MET Full 🗣️: ⭐️ ⭐️ Also on “Oncology Brothers” podcast #OncTwitter OncUpdates OncoAlert #lcsm
1:28

ToxCheck: AEs for ADCs approved in Lung Cancer & how to manage them with Jacob sands: ✅ TDXd: HER2+ ✅ DatoDXd: EGFR+ ✅ TelisoV: C-MET Full 🗣️: ⭐️ ⭐️ Also on “Oncology Brothers” podcast #OncTwitter OncUpdates OncoAlert #lcsm

Oncology Brothers

15,258 görüntüleme • 6 ay önce

#GynOnc: with Shannon Westin, MD, MPH, FASCO we discuss the current treatment landscape/algorithm for #EndometrialCancer Full discussion: - - - Also on the “Oncology Brothers” podcast #gyncsm #MedTwitter #OncTwitter CancerNetwork® #MedX
0:45

#GynOnc: with Shannon Westin, MD, MPH, FASCO we discuss the current treatment landscape/algorithm for #EndometrialCancer Full discussion: - - - Also on the “Oncology Brothers” podcast #gyncsm #MedTwitter #OncTwitter CancerNetwork® #MedX

Oncology Brothers

28,875 görüntüleme • 1 yıl önce

GI Malignancies Conference Highlights from #ASCO26 w/ Namrata (Neena) Vijayvergia MD ✅ #EMERALD3 ✅ #FIGHT302 ✅ #CIRCULATE ✅ #MATTERHORN Full 🗣️ ⭐️ “Oncology Brothers” podcast ⭐️ #OncTwitter #MedTwitter #gism OncUpdates
2:04

GI Malignancies Conference Highlights from #ASCO26 w/ Namrata (Neena) Vijayvergia MD ✅ #EMERALD3 ✅ #FIGHT302 ✅ #CIRCULATE ✅ #MATTERHORN Full 🗣️ ⭐️ “Oncology Brothers” podcast ⭐️ #OncTwitter #MedTwitter #gism OncUpdates

Oncology Brothers

11,714 görüntüleme • 20 gün önce

Treatment Algorithm series: Discussion w/ Emil Lou, MD, PhD, FACP on #PancreaticCancer ✅ NeoAdj/Adj Chemo ✅ Metastatic Panc ✅ PARPi Full 🔊: ⭐️ ⭐️ ⭐️ “Oncology Brothers” podcast #gism #OncTwitter CancerNetwork®
1:10

Treatment Algorithm series: Discussion w/ Emil Lou, MD, PhD, FACP on #PancreaticCancer ✅ NeoAdj/Adj Chemo ✅ Metastatic Panc ✅ PARPi Full 🔊: ⭐️ ⭐️ ⭐️ “Oncology Brothers” podcast #gism #OncTwitter CancerNetwork®

Oncology Brothers

41,671 görüntüleme • 1 yıl önce

GI Cancer Highlights from #ASCO25 w/ Dr. Cathy Eng ✅ #DYNAMIC3 ✅ #ATOMIC ✅ #BREAKWATER ✅ #MATTERHORN ✅ #DESTINYGastric04 Full Discussion: - - Also on the “Oncology Brothers” podcast #gism ASCO #OncTwitter #MedTwitter
1:43

GI Cancer Highlights from #ASCO25 w/ Dr. Cathy Eng ✅ #DYNAMIC3 ✅ #ATOMIC ✅ #BREAKWATER ✅ #MATTERHORN ✅ #DESTINYGastric04 Full Discussion: - - Also on the “Oncology Brothers” podcast #gism ASCO #OncTwitter #MedTwitter

Oncology Brothers

61,635 görüntüleme • 1 yıl önce

Durvalumab (+FLOT) is now U.S. FDA ✅ for resectable Gastric & GEJ adenocarcinoma based off #MATTERHORN! We 🗣️ this trial, findings, PDL1, and AEs w/ Yelena Y. Janjigian MD Full 🗣️: ⭐️ ⭐️ Also on “Oncology Brothers” podcast OncoAlert OncUpdates #gism
1:10

Durvalumab (+FLOT) is now U.S. FDA ✅ for resectable Gastric & GEJ adenocarcinoma based off #MATTERHORN! We 🗣️ this trial, findings, PDL1, and AEs w/ Yelena Y. Janjigian MD Full 🗣️: ⭐️ ⭐️ Also on “Oncology Brothers” podcast OncoAlert OncUpdates #gism

Oncology Brothers

10,064 görüntüleme • 7 ay önce

Treatment Algorithm series: Discussion w/ Tim Brown, MD MSCE on GEJ/Gastric Adeno ✅ ESOPEC ✅ Adj Nivo ✅ Biomarkers: MSI, PDL1, HER2, CLDN18.2 Full 🔊: ⭐️ ⭐️ ⭐️ “Oncology Brothers” podcast #gism #OncTwitter CancerNetwork®
1:10

Treatment Algorithm series: Discussion w/ Tim Brown, MD MSCE on GEJ/Gastric Adeno ✅ ESOPEC ✅ Adj Nivo ✅ Biomarkers: MSI, PDL1, HER2, CLDN18.2 Full 🔊: ⭐️ ⭐️ ⭐️ “Oncology Brothers” podcast #gism #OncTwitter CancerNetwork®

Oncology Brothers

38,272 görüntüleme • 1 yıl önce

As we gear up for #GI26, we discussed testing and the current SoC for HER2+ advanced/metastatic GEJ/Gastric cancer with Rutika Mehta: Full discussion: ⭐️ ⭐️ ⭐️ Also on “Oncology Brothers” podcast #lcsm #OncTwitter OncUpdates
1:19

As we gear up for #GI26, we discussed testing and the current SoC for HER2+ advanced/metastatic GEJ/Gastric cancer with Rutika Mehta: Full discussion: ⭐️ ⭐️ ⭐️ Also on “Oncology Brothers” podcast #lcsm #OncTwitter OncUpdates

Oncology Brothers

11,991 görüntüleme • 6 ay önce